4.7 Article

Loss of iron triggers PINK1/Parkin-independent mitophagy

期刊

EMBO REPORTS
卷 14, 期 12, 页码 1127-1135

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/embor.2013.168

关键词

autophagy; iron/mitophagy; PINK1; Parkin

资金

  1. MRC Protein Phosphorylation and Ubiquitylation Unit DNA Sequencing Service
  2. Medical Research Council
  3. Wellcome Trust Strategic Award [097945/B/11/Z]
  4. Division of Signal Transduction Therapy Unit (AstraZeneca)
  5. Boehringer-Ingelheim
  6. GlaxoSmithKline
  7. Merck KGaA
  8. Janssen Pharmaceutica
  9. Pfizer
  10. Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: researchfish
  11. MRC [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: UKRI

向作者/读者索取更多资源

In this study, we develop a simple assay to identify mitophagy inducers on the basis of the use of fluorescently tagged mitochondria that undergo a colour change on lysosomal delivery. Using this assay, we identify iron chelators as a family of compounds that generate a strong mitophagy response. Iron chelation-induced mitophagy requires that cells undergo glycolysis, but does not require PINK1 stabilization or Parkin activation, and occurs in primary human fibroblasts as well as those isolated from a Parkinson's patient with Parkin mutations. Thus, we have identified and characterized a mitophagy pathway, the induction of which could prove beneficial as a potential therapy for several neurodegenerative diseases in which mitochondrial clearance is advantageous.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据